检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王茜茜 江程[1] WANG Qianqian;JIANG Cheng(School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China)
出 处:《药学进展》2023年第8期626-636,共11页Progress in Pharmaceutical Sciences
摘 要:鞘氨醇-1-磷酸(sphingosine-1-phosphate,S1P)是调节细胞内外多种生物学功能的重要信号分子。S1P通过结合5种G蛋白偶联受体(G protein-coupled receptors,GPCRs)亚型介导多重下游信号通路产生相关的细胞生理功能。近年来,对选择性鞘氨醇-1-磷酸受体1(sphingosine-1-phosphate receptor 1,S1PR1)调节剂的研究已成为发现免疫性疾病治疗药物的热点。综述总结了近年来S1PR1调节剂的研究进展,对构效关系进行了讨论,并在此基础上探讨了此类调节剂的发展方向。Sphingosine-1-phosphate(S1P)is an important signaling molecule that regulates multiple biological functions inside and outside cells.It mediates multiple downstream signaling pathways through binding to five G protein-coupled receptor subtypes to produce related physiological functions of cells.In recent years,the study of selective sphingosine-1-phosphate receptor 1(S1PR1)modulators has become a hot spot in the discovery of therapeutic drugs against immune diseases.This review summarizes the research progress of S1PR1 modulators in recent years,and discusses the structure-activity relationship and the development direction of such modulators.
关 键 词:鞘氨醇-1-磷酸 鞘氨醇-1-磷酸受体1调节剂 免疫性疾病 构效关系
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28